Reliq Total Stockholder Equity vs Cash And Short Term Investments Analysis

RHT Stock  CAD 0.22  0.00  0.00%   
Reliq Health financial indicator trend analysis is much more than just breaking down Reliq Health Technologies prevalent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Reliq Health Technologies is a good investment. Please check the relationship between Reliq Health Total Stockholder Equity and its Cash And Short Term Investments accounts. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Reliq Health Technologies. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

Total Stockholder Equity vs Cash And Short Term Investments

Total Stockholder Equity vs Cash And Short Term Investments Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Reliq Health Technologies Total Stockholder Equity account and Cash And Short Term Investments. At this time, the significance of the direction appears to have strong relationship.
The correlation between Reliq Health's Total Stockholder Equity and Cash And Short Term Investments is 0.63. Overlapping area represents the amount of variation of Total Stockholder Equity that can explain the historical movement of Cash And Short Term Investments in the same time period over historical financial statements of Reliq Health Technologies, assuming nothing else is changed. The correlation between historical values of Reliq Health's Total Stockholder Equity and Cash And Short Term Investments is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Total Stockholder Equity of Reliq Health Technologies are associated (or correlated) with its Cash And Short Term Investments. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Cash And Short Term Investments has no effect on the direction of Total Stockholder Equity i.e., Reliq Health's Total Stockholder Equity and Cash And Short Term Investments go up and down completely randomly.

Correlation Coefficient

0.63
Relationship DirectionPositive 
Relationship StrengthSignificant

Total Stockholder Equity

The total equity held by shareholders, calculated as the difference between a company's total assets and total liabilities. It represents the net value of the company owned by shareholders.

Cash And Short Term Investments

Short Term Investments is an account in the current assets section of Reliq Health Technologies balance sheet. This account contains Reliq Health investments that will expire within one year. These investments include stocks and bonds that can be liquidated by Reliq Health Technologies fairly quickly. The sum of a company's cash on hand, including bank deposits and short-term, highly liquid investments that are easily convertible to known amounts of cash.
Most indicators from Reliq Health's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Reliq Health Technologies current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Reliq Health Technologies. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.
At this time, Reliq Health's Selling General Administrative is fairly stable compared to the past year. Enterprise Value Over EBITDA is likely to climb to 16.73 in 2024, whereas Sales General And Administrative To Revenue is likely to drop 1.28 in 2024.
 2020 2021 2023 2024 (projected)
Cost Of Revenue604.2K3.3M3.7M3.9M
Research Development1.7M2.2M2.6M1.7M

Reliq Health fundamental ratios Correlations

0.790.96-0.36-0.750.80.40.410.80.820.660.120.43-0.360.780.960.760.00.730.620.840.96-0.570.13-0.870.51
0.790.580.25-0.91.0-0.2-0.180.970.930.520.35-0.15-0.451.00.650.98-0.390.840.850.950.62-0.65-0.2-0.880.35
0.960.58-0.59-0.570.590.620.630.610.640.63-0.010.64-0.270.570.970.550.180.580.420.670.99-0.450.27-0.750.5
-0.360.25-0.59-0.150.25-1.0-1.00.260.08-0.250.26-0.98-0.260.26-0.560.29-0.550.280.330.11-0.57-0.13-0.560.03-0.28
-0.75-0.9-0.57-0.15-0.90.090.07-0.84-0.97-0.77-0.550.040.15-0.91-0.65-0.90.23-0.72-0.94-0.96-0.620.40.030.96-0.64
0.81.00.590.25-0.9-0.2-0.190.990.930.530.34-0.15-0.490.990.660.98-0.370.860.850.960.63-0.66-0.2-0.890.35
0.4-0.20.62-1.00.09-0.21.0-0.21-0.020.3-0.20.990.26-0.20.6-0.230.53-0.25-0.27-0.050.60.110.55-0.090.33
0.41-0.180.63-1.00.07-0.191.0-0.20.00.32-0.190.990.26-0.190.61-0.220.53-0.24-0.25-0.030.620.10.56-0.10.35
0.80.970.610.26-0.840.99-0.21-0.20.870.460.25-0.17-0.590.970.650.97-0.410.890.790.930.63-0.68-0.26-0.850.27
0.820.930.640.08-0.970.93-0.020.00.870.750.490.03-0.210.940.720.91-0.160.750.920.980.7-0.560.06-0.950.6
0.660.520.63-0.25-0.770.530.30.320.460.750.470.340.130.530.660.530.140.450.750.720.68-0.20.31-0.830.88
0.120.35-0.010.26-0.550.34-0.2-0.190.250.490.47-0.160.30.380.120.47-0.30.060.590.460.03-0.13-0.19-0.410.51
0.43-0.150.64-0.980.04-0.150.990.99-0.170.030.34-0.160.27-0.150.63-0.180.44-0.24-0.230.00.630.090.5-0.130.38
-0.36-0.45-0.27-0.260.15-0.490.260.26-0.59-0.210.130.30.27-0.43-0.24-0.450.25-0.57-0.1-0.3-0.260.430.240.240.48
0.781.00.570.26-0.910.99-0.2-0.190.970.940.530.38-0.15-0.430.650.98-0.40.830.860.960.61-0.65-0.21-0.880.37
0.960.650.97-0.56-0.650.660.60.610.650.720.660.120.63-0.240.650.630.070.520.470.740.98-0.460.21-0.780.53
0.760.980.550.29-0.90.98-0.23-0.220.970.910.530.47-0.18-0.450.980.63-0.480.810.850.950.58-0.64-0.31-0.870.37
0.0-0.390.18-0.550.23-0.370.530.53-0.41-0.160.14-0.30.440.25-0.40.07-0.48-0.18-0.23-0.250.160.240.920.130.05
0.730.840.580.28-0.720.86-0.25-0.240.890.750.450.06-0.24-0.570.830.520.81-0.180.760.810.57-0.63-0.13-0.780.27
0.620.850.420.33-0.940.85-0.27-0.250.790.920.750.59-0.23-0.10.860.470.85-0.230.760.920.47-0.49-0.06-0.890.65
0.840.950.670.11-0.960.96-0.05-0.030.930.980.720.460.0-0.30.960.740.95-0.250.810.920.71-0.61-0.07-0.960.58
0.960.620.99-0.57-0.620.630.60.620.630.70.680.030.63-0.260.610.980.580.160.570.470.71-0.450.31-0.790.53
-0.57-0.65-0.45-0.130.4-0.660.110.1-0.68-0.56-0.2-0.130.090.43-0.65-0.46-0.640.24-0.63-0.49-0.61-0.450.150.43-0.12
0.13-0.20.27-0.560.03-0.20.550.56-0.260.060.31-0.190.50.24-0.210.21-0.310.92-0.13-0.06-0.070.310.15-0.050.17
-0.87-0.88-0.750.030.96-0.89-0.09-0.1-0.85-0.95-0.83-0.41-0.130.24-0.88-0.78-0.870.13-0.78-0.89-0.96-0.790.43-0.05-0.66
0.510.350.5-0.28-0.640.350.330.350.270.60.880.510.380.480.370.530.370.050.270.650.580.53-0.120.17-0.66
Click cells to compare fundamentals

Reliq Health Account Relationship Matchups

Reliq Health fundamental ratios Accounts

201920202021202220232024 (projected)
Total Assets3.8M2.7M3.5M10.3M11.8M12.4M
Total Current Liabilities1.1M1.4M2.2M3.7M4.3M4.5M
Total Stockholder Equity2.7M1.0M1.0M6.4M7.3M7.7M
Net Debt(345.0K)447.2K176.4K172.2K155.0K162.8K
Retained Earnings(38.9M)(49.9M)(61.7M)(69.9M)(62.9M)(59.7M)
Accounts Payable904.8K1.2M2.1M3.6M4.1M4.3M
Cash345.0K12.8K226.3K132.8K152.7K145.1K
Cash And Short Term Investments468.0K135.8K326.3K232.8K267.7K254.3K
Net Receivables608.8K1.0M2.2M6.4M7.3M7.7M
Common Stock Shares Outstanding118.4M135.2M157.9M183.1M210.5M221.1M
Liabilities And Stockholders Equity3.8M2.7M3.5M10.3M11.8M12.4M
Other Current Assets79.7K97.3K144.6K102.6K118.0K112.1K
Other Stockholder Equity10.1M10.7M12.9M144K165.6K157.3K
Total Liab1.1M1.7M2.5M3.9M4.5M4.7M
Total Current Assets1.2M2.4M3.2M7.0M8.0M8.4M
Other Current Liab144.7K195.9K2.1M3.6M4.1M4.3M
Non Current Assets Total2.5M346.1K283.7K3.3M3.8M4.0M
Accumulated Other Comprehensive Income10.1M10.7M12.9M13.5M15.5M16.3M
Common Stock31.5M40.2M49.8M62.6M72.0M75.6M
Net Tangible Assets2.8M1.0M1.0M6.4M7.3M7.7M
Net Invested Capital2.7M1.0M1.0M6.4M5.8M3.1M
Net Working Capital126.9K938.9K939.9K3.3M2.9M2.3M

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for Reliq Stock Analysis

When running Reliq Health's price analysis, check to measure Reliq Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Reliq Health is operating at the current time. Most of Reliq Health's value examination focuses on studying past and present price action to predict the probability of Reliq Health's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Reliq Health's price. Additionally, you may evaluate how the addition of Reliq Health to your portfolios can decrease your overall portfolio volatility.